Comparison of the efficacy of the tumour necrosis factor alpha blocking agents etanercept and infliximab in patients with active rheumatoid arthritis

被引：0
|
作者：
De Filippis, LG [1 ]
Caliri, A [1 ]
Scibilia, G [1 ]
Miceli, G [1 ]
Romano, C [1 ]
Sangari, D [1 ]
Bartolone, S [1 ]
Lo Gullo, R [1 ]
Bagnato, G [1 ]
机构：
[1] Univ G Martino, Policlin, Rheumatol Unit, Messina, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：411 / 411
页数：1
相关论文
共 50 条
  • [21] Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab
    Matsuno, Hiroaki
    MODERN RHEUMATOLOGY, 2010, 20 (06) : 561 - 565
  • [22] Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis
    McColl, G.
    AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 6 - 6
  • [23] Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
    Otten, Marieke H.
    Prince, Femke H. M.
    ten Cate, Rebecca
    van Rossum, Marion A. J.
    Twilt, Marinka
    Hoppenreijs, Esther P. A. H.
    Koopman-Keemink, Yvonne
    Oranje, Arnold P.
    de Waard-van der Spek, Flora B.
    Gorter, Simone L.
    Armbrust, Wineke
    Dolman, Koert M.
    Wulffraat, Nico M.
    van Suijlekom-Smit, Lisette W. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 337 - 340
  • [24] Etanercept Increases Tumor Necrosis Factor-Alpha Level but not sFas Level in Patients with Rheumatoid Arthritis
    Kotyla, Przemyslaw
    Jankiewicz-Ziobro, Katarzyna
    Owczarek, Aleksander
    Kucharz, Eugene J.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (01): : 14 - 18
  • [25] Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis
    Schmeling, Heinrike
    Horneff, Gerd
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (04) : 383 - 386
  • [26] Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis
    Heinrike Schmeling
    Gerd Horneff
    Rheumatology International, 2007, 27 : 383 - 386
  • [27] Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
    Verhoef, Lise M.
    van den Bemt, Bart J. F.
    van der Maas, Aatke
    Vriezekolk, Johanna E.
    Hulscher, Marlies E.
    van den Hoogen, Frank H. J.
    Jacobs, Wilco C. H.
    van Herwaarden, Noortje
    den Broeder, Alfons A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
  • [28] Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-α antagonists
    Isaacs, John D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (12) : 1463 - 1475
  • [29] Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis
    Yuji Hirano
    Toshihisa Kojima
    Yasuhide Kanayama
    Tomone Shioura
    Masatoshi Hayashi
    Daihei Kida
    Atsushi Kaneko
    Yoshito Eto
    Naoki Ishiguro
    Clinical Rheumatology, 2010, 29 : 495 - 500
  • [30] Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis
    Hirano, Yuji
    Kojima, Toshihisa
    Kanayama, Yasuhide
    Shioura, Tomone
    Hayashi, Masatoshi
    Kida, Daihei
    Kaneko, Atsushi
    Eto, Yoshito
    Ishiguro, Naoki
    CLINICAL RHEUMATOLOGY, 2010, 29 (05) : 495 - 500
12345